Abstract
Abstract
Background
Expanding human presence in space through long-duration exploration missions and commercial space operations warrants improvements in approaches for quantifying crew space radiation health risks. Currently, risk assessment models for radiogenic cancer and cardiovascular disease consider age, sex, and tobacco use, but do not incorporate other modifiable (e.g., body weight, physical activity, diet, environment) and non-modifiable individual risk factors (e.g., genetics, medical history, race/ethnicity, family history) that may greatly influence crew health both in-mission and long-term. For example, clonal hematopoiesis of indeterminate potential (CHIP) is a relatively common age-related condition that is an emerging risk factor for a variety of diseases including cardiovascular disease and cancer. CHIP carrier status may therefore exacerbate health risks associated with space radiation exposure.
Methods
In the present study, published CHIP hazard ratios were used to modify background hazard rates for coronary heart disease, stroke, and hematologic cancers in the National Aeronautics and Space Administration space radiation risk assessment model. The risk of radiation exposure-induced death for these endpoints was projected for a future Mars exploration mission scenario.
Results
Here we show appreciable increases in the lifetime risk of exposure-induced death for hematologic malignancies, coronary heart disease, and stroke, which are observed as a function of age after radiation exposure for male and female crew members that are directly attributable to the elevated health risks for CHIP carriers.
Conclusions
We discuss the importance of evaluating individual risk factors such as CHIP as part of a comprehensive space radiation risk assessment strategy aimed at effective risk communication and disease surveillance for astronauts embarking on future exploration missions.
Funder
Human Research Program of the Human Exploration and Operations Mission Directorate of the National Aeronautics and Space Administration
NASA | Johnson Space Center
Publisher
Springer Science and Business Media LLC
Reference97 articles.
1. Patel, Z. S. et al. Red risks for a journey to the red planet: the highest priority human health risks for a mission to Mars. NPJ Microgravity 6, 33 (2020).
2. Simonsen, L. C., Slaba, T. C., Guida, P. & Rusek, A. NASA’s first ground-based Galactic Cosmic Ray Simulator: enabling a new era in space radiobiology research. PLoS Biol. 18, e3000669 (2020).
3. Afshinnekoo, E. et al. Fundamental biological features of spaceflight: advancing the field to enable deep-space exploration. Cell 183, 1162–1184 (2020).
4. George, K., Rhone, J., Beitman, A. & Cucinotta, F. A. Cytogenetic damage in the blood lymphocytes of astronauts: effects of repeat long-duration space missions. Mutat. Res. Rev. Mutat. Res. 756, 165–169 (2013).
5. George, K. A. et al. Dose response of γ rays and iron nuclei for induction of chromosomal aberrations in normal and repair-deficient cell lines. Radiat. Res. 171, 752–763 (2009).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献